Fibroblast growth factor 21 in metabolic syndrome

Fibroblast growth factor 21 in metabolic syndrome

Metabolic syndrome is a complex metabolic disorder that often clinically manifests as obesity, insulin resistance/diabetes, hyperlipidemia, and hypertension. With the development of social and economic systems, the incidence of metabolic syndrome is increasing, bringing a heavy medical burden. Howev...

Full description

Bibliographic Details
Main Authors: Ming Yang, Chongbin Liu, Na Jiang, Yan Liu, Shilu Luo, Chenrui Li, Hao Zhao, Yachun Han, Wei Chen, Li Li, Li Xiao, Lin Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Endocrinology
Subjects:
FGF21
metabolic syndrome
obesity
diabetes
hyperlipemia
hypertension
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1220426/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1220426/full

Similar Items